New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations. 

New trial results suggest CEM could enhance breast cancer detection beyond DBT exams when patients are faced with barriers to obtaining an MRI.

The LLM’s responses may be misleading in certain situations, which could pose problems for patients who trust the medical advice it provides.

Artificial intelligence could serve as an effective tool for determining which patients may need additional breast MRI sequences mid-protocol.

Prior research has suggested that these incidental lesions turn out to be cancerous in up to 70% of cases, making their timely detection critical. 

Advances in treatment are often credited with improving breast cancer outcomes, but new findings suggest the decrease in mortality may actually be due to improved screening initiatives. 

CT for severe PPH cases could help identify the source of bleeding with greater accuracy, leading to improved management and outcomes. 

It is widely agreed that women with dense breast tissue should undergo supplemental imaging in addition to their routine mammogram screening, but the jury is still out on which modality is best for cancer detection in this group.